SCHEMBL21982459

SCHEMBL21982459

C#CCCCCCCCCC(=O)N1CCC2(CC1)Nc1ccccc1N=C2NCc1cccc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS5 Q9UNA0 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ CACNA1G O43497 1/20 0.34
▸ ADORA3 P0DMS8 2/20 0.34
▸ ADORA2A P29274 2/20 0.34
▸ NAAA Q02083 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ TSHR P16473 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ ENPP2 Q13822 1/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TACR1 P25103 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21982509 0.92 ADAMTS5 (0.34) ADAMTS5KMT2AMEN1CACNA1GADORA3
SCHEMBL17757183 0.85 KDM4E (0.38) ADAMTS5KMT2AMEN1ADORA2AKDM4E
SCHEMBL17992048 0.83 KMT2A (0.40) KMT2AMEN1ADORA2AKDM4ETSHR
SCHEMBL17757184 0.83 HTR1A (0.38) KMT2AMEN1ADORA2AKDM4EMETAP2
SCHEMBL17757185 0.83 THRB (0.38) KMT2AMEN1ADORA2AKDM4ETP53
SCHEMBL17992046 0.82 BRD4 (0.41) KMT2AMEN1ADORA2AKDM4ETSHR
SCHEMBL17992072 0.81 KMT2A (0.38) KMT2AMEN1ADORA3ADORA2AKDM4E
SCHEMBL17992057 0.81 CHRM2 (0.38) KMT2AMEN1ADORA2AKDM4ETSHR
SCHEMBL17757206 0.80 EPHX2 (0.39) KMT2AMEN1ALDH1A1SMN1; SMN2CNR1
SCHEMBL17758032 0.80 ACAT2 (0.39) KMT2AKDM4EMAPTMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 ADAMTS5 1579/4885KMT2A 4518/4885MEN1 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback